Credits: WORCESTER POLYTECHNIC INSTITUTE
Spinach has long been celebrated for the nutritional value it holds, and like we all know, Popeye, too was fan of this superfood, before this term was even popularized. However, spinach has benefits beyond dietary values. It has a unique property that excites biomedical engineers. The properties are its veins, which closely resemble the blood vessels in a human heart.
Creating an artificial heart with so many capillaries is not easy, and if spinach has them already, them why look around?
In 2017, researchers at Worcester Polytechnic Institute (WPI) in Massachusetts repurposed spinach leaves to address a critical medical challenge - that is, the lack of donor organs, especially heart. As per the Organ Donation Statistic, every day, around 17 people die, waiting for an organ transplant on the organ donor list. This could be solved, if this study actually proves to work in favour for those who are waiting in line for heart transplant.
The inspiration among the scientists arose during a casual lunch discussion, which included bioengineers Glenn Gaudette and Joshua Gershlak. Once they recognised the natural structure of spinach veins, they hypothesized that the plant's vein network could serve as a scaffold for growing human heart tissue.
The process began by stripping spinach leaves off their cells, and then turning them translucent by dipping them in detergent, this left behind a cellulose matrix. This material is compatible with the mammalian tissue. This matrix preserved the intricate vein network of the leaf. Researchers then seeded the matrix with human cardiac muscle cells and within the next 5 days, the cells began to contact rhythmically, which mimicked a heartbeat.
While the experiment did not fully create a functional piece of heart muscle, it did mark a significant milestone as the spinach veins were able to transport dyed liquid. This demonstrated their potential to support blood flow in engineered tissues.
Scientists have employed plant resources to produce human tissue before. An apple was previously stripped of its cells by researchers in Ottawa, who reshaped it into a scaffold for cervical tissue. However, the WPI team was the first to investigate the potential of repurposing plant veins for cardiac purposes.
The scientists also conducted experiments with other plants, such as parsley and peanut hairy roots, to demonstrate that diverse plant morphologies may support different types of tissue growth. They even considered exploiting the intricate forms of broccoli or cauliflower to generate lung tissue.
Despite the favorable findings, considerable challenges remain. The researchers must investigate if plant-based scaffolds are rejected in human hosts and develop strategies to improve hybrid tissue. One way is to stack numerous decellularized leaves to produce a thickness similar to human heart walls.
Gaudette and his team hope to one day use their spinach-based scaffolds to mend damaged heart tissue. Their approach has the potential to pave the way for low-cost and accessible organ repair and regeneration treatments.
This one-of-a-kind plant-based application demonstrates how nature's ideas may inspire cutting-edge medical advancements, giving hope to those waiting for lifesaving transplants.
(Credit-Canva)
Even though many studies have been done to determine what foods help our health and which ones could exacerbate or increase the likelihood of certain conditions like cancer, none of them could conclude that for certain. There is always a sense of uncertainty, especially when it comes to food-related research. However, new research has found molecules that can help researchers accurately track this intake, helping them give results with surety.
Researchers have discovered that certain molecules in our blood and urine can show how much energy a person gets from ultraprocessed foods (UPF). This is a huge step because these foods, which are everywhere, make up almost 60% of what Americans eat. Understanding their impact is super important for our health.
In a first of its kind study, published in the PLOS Medicine journal, researchers have pinpointed biological markers, molecules present in our blood and urine, that can reveal how much unhealthy and processed foods we are consuming, whether it is high or low levels of consumption.
One thing you must remember is that these foods are not made at home or with fresh products, these are products that come from factories. These foods range from sugary cereals and sodas to chips and frozen pizzas. These products are industrially produced with ingredients like additives, colors, and preservatives not typically found in home kitchens.
It is difficult to track how certain foods affect us by tracking what we eat. Usually, researchers ask people to remember everything they ate over a certain period. However, these verbal accounts cannot be used for certain, as there will be some disparities regarding what you eat and what you tell. People often forget things or don't report them accurately. This makes it hard to get reliable information.
To overcome this, researchers came up with a new research model that can track food intake through the molecules we carry in our blood and urine.
To create this new, more objective way of tracking food intake, researchers looked at information from a past study involving over 1,000 older adults. A big group of them (more than 700) had given blood and urine samples, and they also kept detailed food diaries for a year.
The scientists then found hundreds of metabolites. These are like little leftover bits that our bodies produce when we digest food and perform other daily functions. They discovered that many of these metabolites were linked to how much energy a person got from ultraprocessed foods. From these, they put together a "score" using 28 markers found in blood and up to 33 markers found in urine. These scores were really good at predicting how much ultraprocessed food someone was eating in their regular diet.
The researchers explained that they found a "signature" – a clear pattern of these markers – that showed a diet high in ultraprocessed foods, not just specific food items. Interestingly, a few of these markers, like certain amino acids (building blocks of protein) and a type of sugar, showed up very consistently. One marker even suggested a possible connection between a diet high in ultraprocessed foods and developing type 2 diabetes.
To make sure their new scoring system actually worked, the team tested it on data from another study that was very carefully controlled. In that study, 20 adults actually lived at an NIH center for a month. For two weeks, they ate only ultraprocessed foods, and for the other two weeks, they ate only unprocessed foods. The researchers made sure both diets had the same amounts of calories, sugar, fat, fiber, and other nutrients, and people could eat as much as they wanted.
The researchers found that their new metabolite scores could accurately tell when a person was eating a lot of ultraprocessed foods and when they weren't. This showed that the markers were reliable for individual people.
Experts believe that these marker "signatures" can help us understand how ultraprocessed foods harm our bodies and even if different types of ultraprocessed foods or processing methods have different effects. The future aspects of this research are huge as many scientists believe they could use it to track how eating ultraprocessed foods affects the risk of getting cancer.
For millions chasing rapid weight loss, Ozempic (semaglutide) has become a household name. As a miracle weight-loss pill, it's being prescribed at record levels throughout the U.S. But as the trend picks up speed, so do the alarms—that from physicians, scientists, and public health advocates. The question is no longer "Does it work?" but "At what cost?
Although semaglutide has undoubtedly enabled some to lose weight, the story further down is a disturbing one: long-term weight loss in many cases is short-lived, side effects are not uncommon, and when they are discontinued, most individuals quickly regain the lost weight.
Originally conceived to treat type 2 diabetes, semaglutide operates by copying the GLP-1 hormone to control appetite and blood glucose. Under the Ozempic and Wegovy labels, it has since blown up in the weight loss industry, with over 137 million American adults now eligible for its application but whereas its advertising brags of speedy solutions, the science paints a grimmer picture.
One recent letter to JAMA Cardiology by Physicians Committee for Responsible Medicine's Dr. Vanita Rahman advises prudence. "Public perception of semaglutide as an obesity solution for the long term must be reassessed," states Rahman. "Yes, it does it for some, but most still have a weight problem—even years after use.
Early results with semaglutide are promising: most patients lose weight in the initial few months. With time, though, this gain decelerates. On average, in the seminal SELECT trial, only 12% of patients achieved a normal body weight after four years on the medication. The majority were overweight or obese.
Even worse is what occurs when individuals discontinue its use. In STEP-1 extension research, individuals regained almost all their lost weight when the drug was withdrawn. This rebound raises grave concerns about sustainability of outcomes—and the psychological damage of yo-yo dieting on a pharmaceutical level.
Semaglutide's promise is accompanied by a longening list of possible side effects. Users often complain about stomach troubles like nausea, vomiting, and diarrhea. But beyond these, new studies point to more serious risks.
In a single observational study, semaglutide was associated with more than four times the risk of nonarteritic anterior ischemic optic neuropathy—a serious although uncommon condition that can cause loss of vision. The risk was even greater among those taking the drug only for weight loss.
In the meantime, its long-term safety is still unmapped territory. With so many new consumers pouring onto the market, doctors are demanding more transparency, improved post-market monitoring, and stricter long-term research.
Though semaglutide might deliver quick results, it's not the sole—or the safest—path to long-term weight loss. Dozens of years of research have conclusively demonstrated that a plant-based, whole-food diet can create meaningful and lasting changes not just in weight, but in overall metabolic function.
The BROAD study, for instance, compared a control group receiving standard care to those eating a low-fat, plant-based diet. After six months, the plant-based group lost 12.1 kg (26.6 pounds) on average, compared to the control group losing just 1.6 kg (3.5 pounds). And the advantages didn't end at the scales—the plant-based group experienced larger decreases in cholesterol, blood pressure, and other significant markers of heart health.
Despite this strong evidence, lifestyle interventions are frequently under-employed. According to a new Physicians Committee/Morning Consult poll, even though half of Americans grasp the advantages of plant-based eating, just 1 in 5 report that their primary care physician talks about it with them. This disconnect between understanding and action perhaps is driving the public's excessive reliance on pill-for-aill fixes.
In the international crusade to make waistlines smaller, it is simple to remember that there is more to health than a digit on the scale. Obesity is a chronic, complex disease with physical, emotional, and social components. There is no one magic pill—however promising—able to treat all of that.
Semaglutide can be a fast route to weight loss, but it doesn't educate healthy habits, it doesn't feed the body, and it doesn't have no side effects. For those contemplating Ozempic, it's important to balance the pros and cons—not only financially, but in terms of maintaining health in the long term.
Ultimately, the most effective weight loss plan is one that promotes your overall health—not for six months, but for the long term. A healthy lifestyle full of whole, plant-based foods, regular exercise, and emotional well-being provides benefits that no injection can match.
Before writing a prescription, ask your doctor about evidence-based nutrition approaches, support for lifestyle, and an all-around plan that places your well-being—not merely your weight—at the forefront.
Credits: Canva
If you’re one of the millions of women struggling with unexplained headaches, body pain, or even fibromyalgia—and you’ve ruled out the usual suspects like stress, sleep, or hormones—it may be time to look inside your mouth. Literally.
A powerful new study in Frontiers in Pain Research revealed a strong link between bad oral hygiene and higher risk of migraines and chronic body pain. The study implies that neglecting your morning brushing and flossing isn't just exposing your teeth to harm—perhaps it's also driving silent inflammation that amplifies pain sensitivity throughout the body.
In a joint study at the University of Sydney, scientists studied 158 New Zealand women, all of whom received thorough dental examinations and gave saliva samples for microbial testing. They compared their self-reported history of migraines, fibromyalgia, and abdominal pain to both their oral health and microbiota. The findings were remarkable.
Women with the poorest oral health—characterized by higher levels of plaque, gum disease, and inflammation—had a 49% greater chance of experiencing migraines and were 60% more likely to experience moderate to severe body pain.
“We’ve long known that oral microbes play a role in systemic inflammation,” said lead researcher Sharon Erdrich, a doctoral candidate at the University of Sydney. “But this is the first study to show a clear link between poor oral health and the kind of widespread pain experienced in fibromyalgia and migraine sufferers.”
The mouth, with more than 700 microbial species calling it home, is an intricate ecosystem. When brushing and flossing routines fail, bad bacteria flourish. These microbes create chemicals that can stimulate inflammation, disrupt neurotransmitter signals, and modulate the nervous system's ability to perceive pain.
Senior researcher Joanna Harnett described how these pain-causing microbial products may pass into the bloodstream and impact pain processing centers in the brain, making one more sensitive to pain.
"Sleep disturbances, headaches, and fatigue—all the hallmarks of fibromyalgia—can have a microbial cause, and it starts in oral hygiene," said Harnett.
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, tender points, fatigue, sleep disturbances, and cognitive problems. It is most commonly found in women aged 20-50 and is notoriously hard to diagnose, going undiagnosed or misdiagnosed for years.
Although the precise etiology is not known, the syndrome has been thought to be related to aberrations in pain signal processing in the brain. There is also emerging evidence of interaction among the immune system, gut microbiota, and recently, the oral microbiome.
For women who experience fibromyalgia or migraines, symptoms tend to flare at random. This research now adds that the status of oral health could be an untapped piece in the diagnostic picture.
Four different microbial species were found to be more common in women who complained of increased pain severity. Researchers are convinced that these microbes affect inflammatory pathways that render receptors for pain more active and sensitive.
This research isn't merely providing an intriguing microbial connection—it's a wake-up call about how we do oral hygiene.
From being a mere topic of pearly whites and good breath, brushing and flossing are now starting to be viewed as weapons in the fight against chronic pain. Better oral hygiene may be an inexpensive, easy-to-reach solution for individuals struggling with migraine, fibromyalgia, or otherwise unexplained pain in the body.
We also hope these findings inspire healthcare professionals to include oral care evaluations in pain treatment plans," Erdrich said. "Particularly for women with chronic, difficult-to-treat diseases."
Although further research is required to comprehend precisely how oral bacteria regulate pain, this research contributes to a mounting body of evidence that the mouth is considerably more linked to overall health than previously believed.
© 2024 Bennett, Coleman & Company Limited